Although the proportion of CD19+ B cells was slightly increased in the CSF of SuS patients, no antibody-producing CD138+ plasma cells were found; the latter being a typical feature of MS CSF (Fig. 1b). This evidence concerns the gene CD19 and myeloid sarcoma.